DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Most users plateau between months 8 and 12. The body adapts to lower caloric intake; weight stabilizes even at maintenance dose. Distinguishing under-dosed vs. genuinely plateaued is the key question.
Weight loss stalls at the dose that previously drove loss. Hunger may slightly increase. Resting metabolic rate has dropped as expected with significant weight loss.
Are you actually under-dosed (still at 1.7 mg Wegovy when 2.4 mg is the trial-maintenance dose)? Did you change food intake unconsciously? Is body composition still improving (smaller waist) even if scale is flat?
Adaptive thermogenesis: ~20-25% reduction in resting metabolic rate per 10% weight loss. This is biology, not failure. Plateaus are expected; they are not the drug failing.
Plateau ≠ failure. First check: are you at the trial-maintenance dose? Second: track protein intake (often quietly drops). Third: switch to Zepbound if on Wegovy maximum dose. Do not stop the drug as the first move.
Editorial summary, not medical advice. Cycling, dose changes, and discontinuation should be coordinated with your prescriber.